AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
Surgical treatment of congenital adrenal hyperplasia
Authors: Schnitzer, JJ Donahoe, PK
Citation: Jj. Schnitzer et Pk. Donahoe, Surgical treatment of congenital adrenal hyperplasia, END METAB C, 30(1), 2001, pp. 137
Mullerian inhibiting substance signaling uses a bone morphogenetic protein(BMP)-like pathway mediated by ALK2 and induces Smad6 expression
Authors: Clarke, TR Hoshiya, Y Yi, SE Liu, XH Lyons, KM Donahoe, PK
Citation: Tr. Clarke et al., Mullerian inhibiting substance signaling uses a bone morphogenetic protein(BMP)-like pathway mediated by ALK2 and induces Smad6 expression, MOL ENDOCR, 15(6), 2001, pp. 946-959
SRY and architectural gene regulation: The kinetic stability of a bent protein-DNA complex can regulate its transcriptional potency
Authors: Ukiyama, E Jancso-Radek, A Li, B Milos, L Zhang, W Phillips, NB Morikawa, N King, CY Chan, G Haqq, CM Radek, JT Poulat, F Donahoe, PK Weiss, MA
Citation: E. Ukiyama et al., SRY and architectural gene regulation: The kinetic stability of a bent protein-DNA complex can regulate its transcriptional potency, MOL ENDOCR, 15(3), 2001, pp. 363-377
Mullerian inhibiting substance inhibits testosterone synthesis in adult rats
Authors: Sriraman, V Niu, E Matias, JR Donahoe, PK MacLaughlin, DT Hardy, MP Lee, MM
Citation: V. Sriraman et al., Mullerian inhibiting substance inhibits testosterone synthesis in adult rats, J ANDROLOGY, 22(5), 2001, pp. 750-758
Mullerian inhibiting substance: An instructive developmental hormone with diagnostic and possible therapeutic applications
Authors: Teixeira, J Maheswaran, S Donahoe, PK
Citation: J. Teixeira et al., Mullerian inhibiting substance: An instructive developmental hormone with diagnostic and possible therapeutic applications, ENDOCR REV, 22(5), 2001, pp. 657-674
Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo
Authors: Stephen, AE Masiakos, PT Segev, DL Vacanti, JP Donahoe, PK MacLaughlin, DT
Citation: Ae. Stephen et al., Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo, P NAS US, 98(6), 2001, pp. 3214-3219
Mullerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents
Authors: Trbovich, AM Sluss, PM Laurich, VM O'Neill, FH NacLaughlin, DT Donahoe, PK Teixeira, J
Citation: Am. Trbovich et al., Mullerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents, P NAS US, 98(6), 2001, pp. 3393-3397
Decreased mitogen activated protein kinase activities in congenital diaphragmatic hernia-associated pulmonary hypoplasia
Authors: Kling, DE Narra, V Islam, S Kinane, TB Alessandrini, A Ercolani, L Donahoe, PK Schnitzer, JJ
Citation: De. Kling et al., Decreased mitogen activated protein kinase activities in congenital diaphragmatic hernia-associated pulmonary hypoplasia, J PED SURG, 36(10), 2001, pp. 1490-1496
Mullerian inhibiting substance regulates NF kappa B signaling and growth of mammary epithelial cells in vivo
Authors: Segev, DL Hoshiya, Y Stephen, AE Hoshiya, M Tran, TT MacLaughlin, DT Donahoe, PK Maheswaran, S
Citation: Dl. Segev et al., Mullerian inhibiting substance regulates NF kappa B signaling and growth of mammary epithelial cells in vivo, J BIOL CHEM, 276(29), 2001, pp. 26799-26806
Perspective: Reproductive tract development - New discoveries and future directions
Authors: MacLaughlin, DT Teixeira, J Donahoe, PK
Citation: Dt. Maclaughlin et al., Perspective: Reproductive tract development - New discoveries and future directions, ENDOCRINOL, 142(6), 2001, pp. 2167-2172
A 13-year-old boy with genital edema and abdominal pain - Crohn's disease of the stomach and the small and large intestines, with metastatic involvement of genital skin.
Authors: Tracy, TF Graeme-Cooke, FM Bramson, RT Israel, E Donahoe, PK Mark, EJ
Citation: Tf. Tracy et al., A 13-year-old boy with genital edema and abdominal pain - Crohn's disease of the stomach and the small and large intestines, with metastatic involvement of genital skin., N ENG J MED, 343(2), 2000, pp. 127-133
A 21-week-old girl with fever and a renal mass - Acute lobar nephronia.
Authors: Peters, CA Nielsen, GP Bramson, RT",Stratton,"Donahoe, PK Mark, EJ Colvin, RB Zitin, MKG
Citation: Ca. Peters et al., A 21-week-old girl with fever and a renal mass - Acute lobar nephronia., N ENG J MED, 342(23), 2000, pp. 1733-1740
Activin receptor-like kinase 1 modulates transforming growth factor-beta 1signaling in the regulation of angiogenesis
Authors: Oh, SP Seki, T Goss, KA Imamura, T Yi, Y Donahoe, PK Li, L Miyazono, K ten Dijke, P Kim, S Li, E
Citation: Sp. Oh et al., Activin receptor-like kinase 1 modulates transforming growth factor-beta 1signaling in the regulation of angiogenesis, P NAS US, 97(6), 2000, pp. 2626-2631
Endogenous expression of Mullerian inhibiting substance in early postnatalrat Sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites
Authors: Watanabe, K Clarke, TR Lane, AH Wang, XZ Donahoe, PK
Citation: K. Watanabe et al., Endogenous expression of Mullerian inhibiting substance in early postnatalrat Sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites, P NAS US, 97(4), 2000, pp. 1624-1629
Mullerian inhibiting substance inhibits breast cancer cell growth through an NF kappa B-mediated pathway
Authors: Segev, DL Ha, TU Tran, TT Kenneally, M Harkin, P Jung, M MacLaughlin, DT Donahoe, PK Maheswaran, S
Citation: Dl. Segev et al., Mullerian inhibiting substance inhibits breast cancer cell growth through an NF kappa B-mediated pathway, J BIOL CHEM, 275(37), 2000, pp. 28371-28379
Human Mullerian-inhibiting substance promoter contains a functional TFII-I-binding initiator
Authors: Morikawa, N Clarke, TR Novina, CD Watanabe, K Haqq, C Weiss, M Roy, AL Donahoe, PK
Citation: N. Morikawa et al., Human Mullerian-inhibiting substance promoter contains a functional TFII-I-binding initiator, BIOL REPROD, 63(4), 2000, pp. 1075-1083
Human ovarian cancer, cell lines, and primary ascites cells express the human mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS
Authors: Masiakos, PT MacLaughlin, DT Maheswaran, S Teixeira, J Fuller, AF Shah, PC Kehas, DJ Kenneally, MK Dombkowski, DM Ha, TU Preffer, FI Donahoe, PK
Citation: Pt. Masiakos et al., Human ovarian cancer, cell lines, and primary ascites cells express the human mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS, CLIN CANC R, 5(11), 1999, pp. 3488-3499
The type I serine threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo
Authors: Gu, ZY Reynolds, EM Song, JH Lei, H Feijen, A Yu, LA He, WW MacLaughlin, DT van den Eijnden-van Raaij, J Donahoe, PK Li, E
Citation: Zy. Gu et al., The type I serine threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo, DEVELOPMENT, 126(11), 1999, pp. 2551-2561
Diagnostic utility of Mullerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors
Authors: Lane, AH Lee, MM Fuller, AF Kehas, DJ Donahoe, PK MacLaughlin, DT
Citation: Ah. Lane et al., Diagnostic utility of Mullerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors, GYNECOL ONC, 73(1), 1999, pp. 51-55
A three-week-old girl with pyloric stenosis and an unexpected operative finding - Pancreatic heterotopia involving the gastric pylorus, with acute pancreatitis. (Hypertrophic pyloric obstruction.)
Authors: Lund, DP Compton, CC Scully, RE Olney, L Ryan, DP Ezekowitz, RAB Donahoe, PK
Citation: Dp. Lund et al., A three-week-old girl with pyloric stenosis and an unexpected operative finding - Pancreatic heterotopia involving the gastric pylorus, with acute pancreatitis. (Hypertrophic pyloric obstruction.), N ENG J MED, 341(9), 1999, pp. 679-684
Transcriptional regulation of the rat Mullerian inhibiting substance type II receptor in rodent Leydig cells
Authors: Teixeira, J Kehas, DJ Antun, R Donahoe, PK
Citation: J. Teixeira et al., Transcriptional regulation of the rat Mullerian inhibiting substance type II receptor in rodent Leydig cells, P NAS US, 96(24), 1999, pp. 13831-13838
Tracheal ligation increases mitogen-activated protein kinase activity and attenuates surfactant protein B mRNA in fetal sheep lungs
Authors: Islam, S Donahoe, PK Schnitzer, JJ
Citation: S. Islam et al., Tracheal ligation increases mitogen-activated protein kinase activity and attenuates surfactant protein B mRNA in fetal sheep lungs, J SURG RES, 84(1), 1999, pp. 19-23
Lack of C-KIT+ mast cells and the development of idiopathic gastric perforation in neonates - Discussion
Authors: Chwals, W Yamataka, A Donahoe, PK
Citation: W. Chwals et al., Lack of C-KIT+ mast cells and the development of idiopathic gastric perforation in neonates - Discussion, J PED SURG, 34(1), 1999, pp. 37-38
Esophagogastric disconnection for gastroesophageal reflux in children withsevere neurological impairment - Discussion
Authors: Jolley, SG Danielson, P Donahoe, PK Holcomb, GW Georgeson, K Tagge, EP King, D
Citation: Sg. Jolley et al., Esophagogastric disconnection for gastroesophageal reflux in children withsevere neurological impairment - Discussion, J PED SURG, 34(1), 1999, pp. 87-87
Reoperation for Hirschsprung's disease - Discussion
Authors: Donahoe, PK Weber, TR Touloukian, R White, JJ Boley, SJ Langer, J
Citation: Pk. Donahoe et al., Reoperation for Hirschsprung's disease - Discussion, J PED SURG, 34(1), 1999, pp. 156-157
Risultati: 1-25 | 26-31